In this fourth meeting of the committee on Addressing Inaccurate and Misleading Information about Biological Threats through Scientific Collaboration and Communication, the committee will meet in closed session to discuss the structure and content of the report, and will establish a plan for the committee's activities moving forward. Inaccurate and misleading information during infectious disease

Dr. Cheston Cunha takes a deep dive into how clinicians and scientists approach the treatment and prevention of SARS-CoV-2 during the global pandemic. This free event is brought to you by the 2021 ASM Clinical Virology Symposium (CVS), one of a 4-part CVS Online: SARS-CoV-2 Webinar Series featuring leading experts in the field discussing the most pressing topics

Many conversations surrounding the COVID-19 pandemic were framed as a trade-off between individual liberties and the health of the public. Was this the right framing? What are the implications of the moment for future conversations? This program is a part of “The Next Normal” series, designed to take a moment to pause and ask, as

Emerging technologies have the potential to modernize pharmaceutical manufacturing and advance the quality of drug products. The National Academies of Sciences, Engineering, and Medicine; Division on Earth and Life Studies; Board on Chemical Sciences and Technology; Committee to Identify Innovative Technologies to Advance Pharmaceutical Manufacturing released a report which identifies these innovative technologies, including manufacturing processes, control and